Atish Majumdar
Tracked across 1 events · 6 articles · First seen Aug 20, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Mankind Pharma has entered into an exclusive in-licensing and marketing agreement with Chongqing Chenan Biopharmaceutical Co., Ltd., a China-based biopharmaceutical company, to commercialize two insulin analogues in India: Insulin Degludec and a combination of Insulin…
Impact: Atish Majumdar, Senior President of Sales and Marketing at Mankind Pharma, is the spokesperson for the agreement, articulating the company's strategy and commitment to expanding its in-licensing pipeline from China.
Aug 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Atish Majumdar live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard